Oral Session 2-11D CML: Basic (2)

[OS2-11D-3] Efficacy of OR-21, a new oral DNA methyltransferase inhibitor in chronic myeloid leukemia

Kazuharu Kamachi^1,2, Hiroshi Ureshino^1,2, Yuki Kurahashi³, Yuki Kurahashi³, Tatsuro Watanabe², Seiji Okada⁴, Shinya Kimura^1,2 (1.Hematology, Respiratory Medicine and Oncology, Saga University, Saga, Japan, 2.Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan, 3.OHARA Pharmaceutical Co., Ltd, 4.Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection)